pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 10·1 min read
save

States urged to use low-cost, scalable outreach for Medicaid enrollees facing 2027 eligibility changes

Aug 10, 2026·read at STAT ↗Neutral

States must begin notifying Medicaid beneficiaries about upcoming eligibility changes by September, as required by the One Big Beautiful Bill Act of 2025. The changes, set to take effect in 2027, introduce work requirements and twice-yearly eligibility checks that could lower enrollment numbers.

The legislation mandates that each state use at least two outreach methods, but leaves the choice of channels to the states themselves. Officials worry the new rules may create confusion for enrollees trying to understand their obligations.

A recent study by health-policy researchers examined which communication approaches are most cost-effective, scalable, and impactful. The analysis identified low-cost, high-reach tactics that could help states meet the outreach requirement without excessive spending.

The authors suggest that states adopt these evidence-based methods to reduce administrative burden and improve enrollment continuity as the 2027 deadline approaches.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: How should states reach out to Medicaid enrollees affected by changes? Our research gives a hint”

read at STAT ↗
1,576 words · retrieved Aug 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Emory University2

related stories

  • Sep 8FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancerFierce Biotech
  • Sep 8Opinion: It’s time to take the gloves off during vaccinationSTAT
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 24Nurse practitioner trainees find themselves stymied by shortage of clinical mentorsSTAT
  • Jul 2Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none existsSTAT